FDA removes holds on Genentech's omalizumab

According to DNA partner Tanox (TNOX), the FDA lifted its holds and partial holds on trials of omalizumab ( rhuMAb-E25), a humanized monoclonal antibody against IgE being developed by DNA, TNOX and No...